Overexpression of carbonyl reductase 1 in ovarian cancer cells suppresses proliferation and activates the eIF2 signaling pathway
Yuka Kadonosawa(Hirosaki University), Yoshihito Yokoyama(Hirosaki University)
Cited by 0
Related Papers
Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 Trial
|NEJM Evidence|2023|31
Carbonyl reductase 1-overexpressing exosomes inhibit proliferation of ovarian cancer cells
|Institutional Repositories DataBase (IRDB)|2021|0